Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
21-24 October, 2025
AllPack IndonesiaAllPack Indonesia
Not Confirmed
Not Confirmed
21-25 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
21-24 October, 2025
AllPack IndonesiaAllPack Indonesia
Industry Trade Show
Not Confirmed
21-25 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
08 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-08/immunitybio-s-anktiva-reverses-lymphopenia-and-extends-overall-survival-in-patients-with-advanced-n
26 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250826147574/en/Initial-Data-Shows-100-Disease-Control-in-5-Out-of-5-Patients-With-Recurrent-Glioblastoma-With-Two-Patients-in-Near-Complete-Response-Treated-With-ImmunityBios-ANKTIVA-NK-Cell-Therapy-Plus-Optune-Gio-Device
19 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250819968042/en/ImmunityBio-Announces-Phase-2-Study-of-ANKTIVA-in-Patients-with-Long-COVID
13 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250813610481/en/ImmunityBio-Reports-Complete-Responses-in-Non-Hodgkin-Waldenstrom-Lymphoma-Patients-with-Chemotherapy-Free-First-In-Class-CD19-CAR-NK-Immunotherapy
11 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250811438303/en/ImmunityBio-Announces-Houstons-Michael-E.-DeBakey-VA-Medical-Center-Is-Among-the-First-VA-Hospitals-to-Administer-ANKTIVA-to-Bladder-Cancer-Patients
05 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250805482884/en/ImmunityBio-Reports-Q2-Earnings-Release-Reflecting-60-Increase-in-Revenue-in-Q2-2025-With-Year-to-Date-Sales-of-%2443-Million-and-246-Unit-Growth-Since-J-code
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE